Z-1520-2018 Class III Terminated

Recalled by Diagnostic Hybrids, Inc. — Athens, OH

FDA device recall Z-1520-2018 was initiated by Diagnostic Hybrids, Inc. on Oct 26, 2016 and is designated Class III. Reason for recall: There may be a loss of separation between Calibrators A and B which may impact the assay calibration at the lower end of the assay. The recall status is terminated (terminated Aug 28, 2020). Affected quantity: 26.

Recall details

Product Type
Devices
Report Date
May 2, 2018
Initiation Date
Oct 26, 2016
Termination Date
Aug 28, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
26

Product description

Quidel MicroVue Intact PTH EIA, Model 8044. An enzyme immunoassay for the quantification of Intact Parathyroid Hormone (PTH) in serum.

Reason for recall

There may be a loss of separation between Calibrators A and B which may impact the assay calibration at the lower end of the assay.

Distribution pattern

The product was distributed to the following countries: Singapore, Switzerland

Code information

Lot 068259

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1520-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1520-2018. Report a data issue: hello@regdatalab.com.